Back
Alnylam Pharmaceuticals 10K Form
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
265.13
Seasonality Move:
13.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | ALNY/Alnylam Pharmaceuticals Quarterly |
2023-11-02 | 10Q | ALNY/Alnylam Pharmaceuticals Quarterly |
2023-08-03 | 10Q | ALNY/Alnylam Pharmaceuticals Quarterly |
2023-05-04 | 10Q | ALNY/Alnylam Pharmaceuticals Quarterly |
2022-10-27 | 10Q | ALNY/Alnylam Pharmaceuticals Quarterly |
2022-07-28 | 10Q | ALNY/Alnylam Pharmaceuticals Quarterly |
Receive ALNY News And Ratings
See the #1 stock for the next 7 days that we like better than ALNY
ALNY Financial Statistics
Sales & Book Value
Annual Sales: | $1.83B |
---|---|
Cash Flow: | $39.52M |
Price / Cash Flow: | 2093.7 |
Annual Sales: | $0.25 |
Price / Book: | 1057.59 |
Profitability
EPS (TTM): | -2.62000 |
---|---|
Net Income (TTM): | $-332.26M |
Gross Margin: | $1.52B |
Return on Equity: | 0% |
Return on Assets: | -8.43% |
Alnylam Pharmaceuticals Earnings Forecast
Key Alnylam Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 19 years for ALNY is 83.02%.
- The Selling, General & Administrative Expenses for ALNY have been equal to 43.52% of Gross Profit Margin.
- The Research & Development expenses have been 54.94% of Revenue.
- The Interest Expense is -27.54% of Operating Income.
- The Net Earning history of ALNY is -24.08% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 10 years.
Alnylam Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | ALNY |
CUSIP: | 02043Q |
Website: | alnylam.com |
Debt
Debt-to-Equity Ratio: | 31.64 |
---|---|
Current Ratio: | 2.75 |
Quick Ratio: | 2.57 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 524.56 |
ALNY Technical Analysis vs Fundamental Analysis
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $265.29. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.